297 related articles for article (PubMed ID: 27559710)
1. Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.
Del Prete GQ; Lifson JD; Keele BF
Curr Opin HIV AIDS; 2016 Nov; 11(6):546-554. PubMed ID: 27559710
[TBL] [Abstract][Full Text] [Related]
2. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.
Staprans SI; Feinberg MB
Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703
[TBL] [Abstract][Full Text] [Related]
3. Nonhuman primate models for HIV/AIDS vaccine development.
Sui Y; Gordon S; Franchini G; Berzofsky JA
Curr Protoc Immunol; 2013 Oct; 102():12.14.1-12.14.30. PubMed ID: 24510515
[TBL] [Abstract][Full Text] [Related]
4. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
[TBL] [Abstract][Full Text] [Related]
5. New directions for HIV vaccine development from animal models.
McChesney MB; Miller CJ
Curr Opin HIV AIDS; 2013 Sep; 8(5):376-81. PubMed ID: 23836045
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of AIDS vaccine strategies in nonhuman primates.
Uberla K
Med Microbiol Immunol; 2005 Aug; 194(4):201-6. PubMed ID: 15843997
[TBL] [Abstract][Full Text] [Related]
7. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
8. HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
Voronin Y; Phogat S
Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672
[TBL] [Abstract][Full Text] [Related]
9. Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates.
Warren JT; Levinson MA
J Med Primatol; 1997; 26(1-2):63-81. PubMed ID: 9271191
[No Abstract] [Full Text] [Related]
10. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
Van Rompay KK
AIDS Res Hum Retroviruses; 2012 Jan; 28(1):16-35. PubMed ID: 21902451
[TBL] [Abstract][Full Text] [Related]
11. Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.
Lifson JD; Haigwood NL
Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007310. PubMed ID: 22675663
[TBL] [Abstract][Full Text] [Related]
12. Nonhuman primate models for HIV vaccine development.
Letvin NL
Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
[TBL] [Abstract][Full Text] [Related]
13. HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infection.
Lynch RM; Yamamoto T; McDermott AB
Curr Opin HIV AIDS; 2013 Jul; 8(4):288-94. PubMed ID: 23666390
[TBL] [Abstract][Full Text] [Related]
14. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
[TBL] [Abstract][Full Text] [Related]
15. A high throughput lentivirus sieving assay identifies neutralization resistant Envelope sequences and predicts in vivo sieving.
Iwamoto N; Mason R; Hu J; Ransier A; Welles H; Song K; Douek D; Roederer M
J Immunol Methods; 2019 Jan; 464():64-73. PubMed ID: 30389575
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates.
Schmitz JE; Korioth-Schmitz B
Curr Opin HIV AIDS; 2013 Jul; 8(4):273-9. PubMed ID: 23615117
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
18. Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates.
Warren J
J Med Primatol; 2002 Aug; 31(4-5):237-56. PubMed ID: 12390546
[TBL] [Abstract][Full Text] [Related]
19. Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials.
Shedlock DJ; Silvestri G; Weiner DB
Nat Rev Immunol; 2009 Oct; 9(10):717-28. PubMed ID: 19859066
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.
Lee FH; Mason R; Welles H; Learn GH; Keele BF; Roederer M; Bar KJ
J Virol; 2015 Dec; 89(24):12388-400. PubMed ID: 26423953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
